Cardiovascular Systems logo
Cardiovascular Systems CSII

Quarterly report 2022-Q4
added 02-09-2023

report update icon

Cardiovascular Systems Total Assets 2011-2026 | CSII

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.
Main categories of assets
Current assets (used within one year):
  • Cash and cash equivalents
  • Accounts receivable (amounts owed by customers)
  • Inventory of goods, raw materials, and supplies
  • Short-term investments
Non-current assets (used for more than one year):
  • Fixed assets (buildings, machinery, equipment)
  • Intangible assets (brands, patents, software)
  • Long-term investments
  • Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets Cardiovascular Systems

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
323 M 353 M 340 M 219 M 203 M 194 M 142 M 171 M 182 M 96.9 M 63.1 M 46.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
353 M 46.8 M 194 M

Quarterly Total Assets Cardiovascular Systems

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
312 M 312 M 323 M 324 M 326 M 332 M 353 M 353 M 349 M 342 M 340 M 220 M 224 M 217 M 219 M 219 M 207 M 200 M 203 M 203 M 190 M 190 M 194 M 194 M 159 M 138 M 142 M 142 M 151 M 162 M 171 M 171 M 181 M 182 M 182 M 182 M 181 M 95.1 M 96.9 M 96.9 M 56.6 M 60.1 M 63.1 M 63.1 M 52 M 48.3 M 46.8 M 46.8 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
353 M 46.8 M 192 M

Total Assets of other stocks in the Medical devices industry

Issuer Total Assets Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
224 M - - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
659 M - - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
62.4 M - 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
54 M - -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
19.7 M - 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
10.6 M - -5.86 % $ 30.6 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
842 K - 37.08 % $ 85.7 M usaUSA
Conformis Conformis
CFMS
94 M - - $ 16.4 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
34.4 M $ 1.35 - $ 21.8 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
110 M - - $ 475 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
851 M $ 11.72 -1.26 % $ 464 M curacaoCuracao
LENSAR LENSAR
LNSR
66.3 M $ 5.56 -8.4 % $ 64 M usaUSA
Avinger Avinger
AVGR
13.8 M - -20.74 % $ 369 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
789 M - -4.14 % $ 702 M usaUSA
AxoGen AxoGen
AXGN
222 M $ 32.61 2.71 % $ 1.5 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
2.33 B $ 36.56 -0.19 % $ 1.13 B usaUSA
Penumbra Penumbra
PEN
1.83 B $ 334.17 -0.41 % $ 13 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
33.8 M - -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
10.5 K - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
64.1 M - 0.03 % $ 1.58 B israelIsrael
Electromed Electromed
ELMD
53.8 M $ 24.7 0.86 % $ 209 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
204 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
66.2 M - - $ 111 M canadaCanada
Insulet Corporation Insulet Corporation
PODD
3.19 B $ 225.5 -0.7 % $ 15.9 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
227 M - - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
47.4 M $ 0.7 3.3 % $ 38.1 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
7.36 M $ 2.16 -6.09 % $ 3.37 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
43.9 M $ 5.15 -4.63 % $ 180 M canadaCanada
BIOLASE BIOLASE
BIOL
35.1 M - -13.19 % $ 166 K usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
419 M $ 3.82 -3.05 % $ 163 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
4.32 B $ 11.48 10.7 % $ 1.55 B usaUSA
Myomo Myomo
MYO
38.6 M $ 0.7 -1.83 % $ 29.3 M usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
210 M $ 2.4 -1.64 % $ 141 M israelIsrael
Invacare Corporation Invacare Corporation
IVC
771 M - - $ 24.7 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
86.1 M $ 3.91 4.83 % $ 146 M franceFrance
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
509 M $ 15.91 -3.4 % $ 373 M usaUSA
Outset Medical Outset Medical
OM
264 M $ 3.53 -2.35 % $ 53.7 K usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
907 M $ 52.07 -0.17 % $ 1.53 B usaUSA
Sintx Technologies Sintx Technologies
SINT
9.51 M $ 2.57 0.78 % $ 7.13 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
129 M $ 1.31 -5.76 % $ 53.3 M usaUSA
Cutera Cutera
CUTR
346 M - -10.19 % $ 1.99 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
15.4 M - 14.99 % $ 929 K usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
53 M $ 3.96 -3.65 % $ 64.7 M usaUSA
InspireMD InspireMD
NSPR
69.4 M $ 1.79 3.47 % $ 115 M israelIsrael
Eargo Eargo
EAR
132 M - - $ 10.2 M usaUSA
NuVasive NuVasive
NUVA
2.22 B - - $ 2.07 B usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
41.6 M - -0.97 % $ 54.4 M usaUSA